These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11674927)

  • 1. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report.
    Trujillo MJ; de Barrio M; Rodríguez A; Moreno-Zazo M; Sánchez I; Pelta R; Tornero P; Herrero T
    Allergol Immunopathol (Madr); 2001; 29(4):133-6. PubMed ID: 11674927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam.
    Gonçalo M; Figueiredo A; Tavares P; Ribeiro CA; Teixeira F; Baptista AP
    Contact Dermatitis; 1992 Nov; 27(5):287-90. PubMed ID: 1493681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to thimerosal and photosensitivity to piroxicam.
    de Castro JL; Freitas JP; Brandão FM; Themido R
    Contact Dermatitis; 1991 Mar; 24(3):187-92. PubMed ID: 1868702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam-induced photosensitivity and contact sensitivity to thiosalicylic acid.
    Serrano G; Bonillo J; Aliaga A; Cuadra J; Pujol C; Pelufo C; Cervera P; Miranda MA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):479-83. PubMed ID: 2212148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sensitivity among oxicams in piroxicam-caused fixed drug eruption: two case reports.
    Ordoqui E; De Barrio M; Rodríguez VM; Herrero T; Gil PJ; Baeza ML
    Allergy; 1995 Sep; 50(9):741-4. PubMed ID: 8546269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What risk of piroxicam photodermatitis in thimerosal-positive patients?
    Stingeni L; Lapomarda V; Lisi P
    Contact Dermatitis; 1996 Jan; 34(1):60-1. PubMed ID: 8789229
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-pigmenting cutaneous-mucosal fixed drug eruption due to piroxicam.
    Montoro J; Díaz M; Genís C; Lozano A; Bertomeu F
    Allergol Immunopathol (Madr); 2003; 31(1):53-5. PubMed ID: 12573211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.
    Ben Romdhane H; Ammar H; Ben Fadhel N; Chadli Z; Ben Fredj N; Boughattas NA; Chaabane A; Aouam K
    Contact Dermatitis; 2019 Jul; 81(1):24-26. PubMed ID: 30663057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethylmercuric chloride: the responsible agent in thimerosal hypersensitivity.
    Pirker C; Möslinger T; Wantke F; Götz M; Jarisch R
    Contact Dermatitis; 1993 Sep; 29(3):152-4. PubMed ID: 8222628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxicam-induced photosensitivity. Patch and photopatch testing studies with tenoxicam and piroxicam photoproducts in normal subjects and in piroxicam-droxicam photosensitive patients.
    Serrano G; Fortea JM; Latasa JM; SanMartin O; Bonillo J; Miranda MA
    J Am Acad Dermatol; 1992 Apr; 26(4):545-8. PubMed ID: 1597539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity between sensitivity to thimerosal and photosensitivity to piroxicam in guinea pigs.
    Kitamura K; Osawa J; Ikezawa Z; Nakajima H
    Contact Dermatitis; 1991 Jul; 25(1):30-4. PubMed ID: 1935030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to thimerosal: the sensitizing moiety.
    Goncalo M; Figueiredo A; Goncalo S
    Contact Dermatitis; 1996 Mar; 34(3):201-3. PubMed ID: 8833465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photocontact dermatitis due to piroxicam: photopatch testing.
    Torinuki W
    Tohoku J Exp Med; 1992 Aug; 167(4):267-71. PubMed ID: 1488748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitivity to piroxicam is induced by sensitization to thimerosal and thiosalicylate.
    Ikezawa Z; Kitamura K; Osawa J; Hariya T
    J Invest Dermatol; 1992 Jun; 98(6):918-22. PubMed ID: 1593152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam-induced photosensitive dermatitis.
    McKerrow KJ; Greig DE
    J Am Acad Dermatol; 1986 Dec; 15(6):1237-41. PubMed ID: 2948973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of cross-sensitivity between thiosalicylic acid, a contact allergen, and piroxicam, a photoallergen.
    de la Cuadra J; Pujol C; Aliaga A
    Contact Dermatitis; 1989 Nov; 21(5):349-51. PubMed ID: 2620517
    [No Abstract]   [Full Text] [Related]  

  • 17. Piroxicam has at least two epitopes for contact photoallergy.
    Hariya T; Osawa J; Kitamura K; Ikezawa Z
    J Dermatol Sci; 1993 Dec; 6(3):219-24. PubMed ID: 7510999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of photosensitive reactions induced by piroxicam.
    Cirne de Castro JL; Vale E; Martins M
    J Am Acad Dermatol; 1989 Apr; 20(4):706-7. PubMed ID: 2523906
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed drug eruption from piroxicam.
    Cuerda Galindo E; Goday Buján JJ; García Silva JM; Martínez W; Verea Hernando M; Fonseca E
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):586-7. PubMed ID: 15324401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral piroxicam-induced dyshidrosiform dermatitis.
    Piqué E; Pérez JA; Benjumeda A
    Contact Dermatitis; 2004 Jun; 50(6):382-3. PubMed ID: 15274738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.